AMEX · PMI
Healthcare · Medical - Devices
$8.44
Down-$0.56 (-6.22%)
Updated Nov 10, 2026, 5:36 AM
SID Score
4.1/10
Composite research score
Smart Money
58/100
Neutral
Price performance · PMI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 9, 2026
PMI closed at $8.44 after 21 trading sessions, down 25.57% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 9, 2026 | $8.16 | $8.77 | $8.00 | $8.44 | 19.78K |
| Nov 6, 2026 | $7.85 | $9.14 | $7.6833 | $9.00 | 45K |
| Nov 5, 2026 | $7.30 | $8.01 | $6.56 | $7.85 | 58.18K |
| Nov 4, 2026 | $7.851 | $8.00 | $7.19 | $7.19 | 31.87K |
| Nov 3, 2026 | $8.72 | $9.52 | $7.42 | $7.78 | 97.35K |
| Nov 2, 2026 | $8.42 | $9.14 | $8.35 | $8.58 | 41.47K |
| Oct 30, 2026 | $8.15 | $8.81 | $7.74 | $8.35 | 56.34K |
| Oct 29, 2026 | $7.14 | $8.40 | $7.12 | $8.11 | 71.09K |
| Oct 28, 2026 | $6.86 | $7.30 | $6.84 | $7.23 | 44.27K |
| Oct 27, 2026 | $6.69 | $6.9725 | $6.50 | $6.83 | 52.96K |
| Oct 26, 2026 | $7.14 | $7.305 | $6.4004 | $6.43 | 76.51K |
| Oct 23, 2026 | $7.05 | $8.30 | $7.0301 | $7.09 | 88.6K |
| Oct 22, 2026 | $9.35 | $9.53 | $7.00 | $7.37 | 331.01K |
| Oct 21, 2026 | $11.01 | $11.055 | $9.18 | $9.63 | 422.08K |
| Oct 20, 2026 | $15.20 | $17.47 | $10.14 | $10.48 | 1.01M |
| Oct 19, 2026 | $13.59 | $15.60 | $12.32 | $15.45 | 748.92K |
| Oct 16, 2026 | $12.21 | $13.1584 | $8.38 | $12.75 | 1.61M |
| Oct 15, 2026 | $13.67 | $18.23 | $10.00 | $10.00 | 1.49M |
| Oct 14, 2026 | $13.61 | $14.50 | $12.68 | $12.68 | 160.87K |
| Oct 13, 2026 | $11.22 | $17.50 | $10.5903 | $15.33 | 1.18M |
| Oct 12, 2026 | $9.15 | $12.69 | $9.0125 | $11.34 | 693.87K |
The latest Smart Investors Daily articles mentioning PMI.
Company
Market Activity
Research & News
PMI research
Company profile and research snapshot.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 3, 2026 | HC Wainwright & Co. | Neutral | — |
| May 18, 2026 | HC Wainwright & Co. | Neutral | — |
No generated briefing is available yet.
Yahoo · Nov 5, 2026
CareCloud (CCLD) delivered earnings and revenue surprises of +16.67% and +0.69%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · Nov 3, 2026
American Well (AMWL) delivered earnings and revenue surprises of -1.52% and +4.10%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Benzinga · Nov 3, 2026
On October 28, 2026, the Board of Directors (the "Board") of Picard Medical, Inc., a Delaware company (the "Company") appointed Richard Fang, Ph.D., as the Company’s Chief Executive Officer on a
Benzinga · Oct 20, 2026
Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 19.3% to $1.14 during Tuesday's after-market session. The company's market cap stands at $1.8 million. Edesa Biotech (NASDAQ:EDSA) shares rose
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PMI.
